Converting FGFR inhibitors into selective covalent molecular glue degraders via transposable gluing handles
European Journal of Medicinal Chemistry · 2026-10 · 316 · 119034
DOI: 10.1016/j.ejmech.2026.119034 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Medicinal Chemistry, 2026-10. Verfasst von Xiansheng Cao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Provincial Key Laboratory of Drug Discovery and Safety Evaluation for Inflammatory Chronic Diseases, School of Pharmacy, Hangzhou Medical Co…. Hauptthemen laut MEDLINE: Protein Kinase Inhibitors, Receptor, Fibroblast Growth Factor, Type 2, Antineoplastic Agents. Die Arbeit nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Molecular glue degraders (MGDs) have emerged as a transformative therapeutic modality, offering the potential to deplete undruggable or pathogenic proteins. However, the rational design of MGDs remains inherently challenging compared to traditional heterobifunctional degraders. Recently, the implementation of transposable chemical gluing handles has provided an efficient approach to convert established protein-targeting ligands into target-specific MGDs. In this study, by incorporating diverse molecular glue handles and amino acid-based degrons into the solvent-exposed exit vectors of infigratinib, we synthesized a library of 30 candidate MGDs. Preliminary screening and subsequent lead optimization identified LC-MG-5 and LC-MG-10 as highly efficient degraders of FGFR2. In cellular models, both compounds demonstrated potent suppression of FGFR2-mediated signaling pathways. Mechanistic investigations revealed that the covalent engagement of the gluing handle is a critical determinant for successful proteasomal degradation of FGFR2. This work provides a framework for the rational transformation of kinase inhibitors into covalent molecular glue degraders, underscoring the potential of FGFR degradation as a next-generation precision medicine strategy for FGFR2-driven malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhejiang Provincial Key Laboratory of Drug Discovery and Safety Evaluation for Inflammatory Chronic Diseases, School of Pharmacy, Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China.
- Zhejiang Provincial Key Laboratory of Drug Discovery and Safety Evaluation for Inflammatory Chronic Diseases, School of Pharmacy, Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China; Department of Pharmacy, Zhej…
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Cao, X., Huang, X., Song, C., Shi, S., Zhu, Y., Zheng, L., Liang, G., & Chen, L. (2026). Converting FGFR inhibitors into selective covalent molecular glue degraders via transposable gluing handles. European Journal of Medicinal Chemistry, 316, 119034. https://doi.org/10.1016/j.ejmech.2026.119034
Vancouver
Cao X, Huang X, Song C, Shi S, Zhu Y, Zheng L, et al. Converting FGFR inhibitors into selective covalent molecular glue degraders via transposable gluing handles. European Journal of Medicinal Chemistry. 2026;316:119034. doi:10.1016/j.ejmech.2026.119034
BibTeX
@article{Cao2026,
author = {Cao, Xiansheng and Huang, Xiaohao and Song, Chongran and Shi, Shu and Zhu, Yongjuan and Zheng, Lulu and Liang, Guang and Chen, Lingfeng},
title = {Converting FGFR inhibitors into selective covalent molecular glue degraders via transposable gluing handles},
journal = {European Journal of Medicinal Chemistry},
year = {2026},
volume = {316},
pages = {119034},
doi = {10.1016/j.ejmech.2026.119034}
}
EUVIMED